<DOC>
	<DOC>NCT01204541</DOC>
	<brief_summary>This study seeks to evaluate a novel endpoint for future dry AMD clinical trials.</brief_summary>
	<brief_title>A Single-Center Pilot Study to Assess Macular Function</brief_title>
	<detailed_description />
	<mesh_term>Macular Degeneration</mesh_term>
	<criteria>Subjects in good health aged 2029 or 6090 years (normal cohorts) Subjects with early nonexudative agerelated macular degeneration (AMD cohort) Enrollment in a investigational drug or device study and have used an investigational drug or device within 7 days of enrollment into this study</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>February 2012</verification_date>
	<keyword>Non-exudative age-related macular degeneration</keyword>
</DOC>